NHFG
EW icon

New Harbor Financial Group’s Edwards Lifesciences EW Stock Holding History

New Harbor Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,200
Closed -$13K – 104
2013
Q4 		$13K Hold
1,200
– – 0.02% 64
2013
Q3 		$14K Hold
1,200
– – 0.02% 60
2013
Q2 		$13K Buy
+1,200
New +$14.2K 0.02% 64

Other funds holding EW

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

New Harbor Financial Group's EW Position: Q1 2014 in Review

New Harbor Financial Group sold out of Edwards Lifesciences (EW) in Q1 2014, closing a stake of 1,200 shares — an estimated $13K sold.

New Harbor Financial Group first reported a position in EW in Q2 2013 and held it in 3 quarters. The position peaked at $14K in Q3 2013. 409 funds tracked by Wall St. Rank hold EW as of Q1 2014.

  • New Harbor Financial Group reported no remaining Edwards Lifesciences position as of Q1 2014 after selling out during the quarter.
  • New Harbor Financial Group sold 1,200 Edwards Lifesciences shares in Q1 2014, an estimated $13K.
  • New Harbor Financial Group first reported a position in Edwards Lifesciences in Q2 2013 and held it in 3 quarters.
  • New Harbor Financial Group's Edwards Lifesciences position peaked at $14K in Q3 2013.
  • 409 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2014.

Based on New Harbor Financial Group's 13F filing for Q1 2014, filed 12 May 2014.